Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.14% |
| 10 | Tarsus Pharmaceuticals | 3.96 Bn | 3.51 Bn | 161.80 Mn | 543.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 543.90% |
| Mar 31, 2026 | 534.09% |
| Dec 31, 2025 | 404.11% |
| Sep 30, 2025 | 140.12% |
| Jun 30, 2025 | 41.99% |
| Mar 31, 2025 | 108.30% |
| Dec 31, 2024 | 57.63% |
| Sep 30, 2024 | 48.27% |
| Jun 30, 2024 | 45.43% |
| Mar 31, 2024 | 12.15% |
| Dec 31, 2023 | 53.40% |
| Sep 30, 2023 | 69.72% |
| Jun 30, 2023 | 60.02% |
| Mar 31, 2023 | 30.38% |
| Dec 31, 2022 | 26.75% |
| Sep 30, 2022 | 83.24% |
| Jun 30, 2022 | 100.21% |
| Mar 31, 2022 | 55.35% |
| Dec 31, 2021 | 37.77% |
| Sep 30, 2021 | -14.07% |